ESR1 and breast carcinoma: Transcriptional profiling of estrogen responses in ER-positive human breast cancer cell lines and model systems in vitro leads to changes in the transcription of large numbers of genes [8,9], but very little is known of these effects in vivo or how these effects vary between tumours and whether these molecular changes fully encompass the determinants of clinical response.